These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 19379368)

  • 1. Iron management in hemodialysis patients: optimizing outcomes in Vicenza, Italy.
    Crepaldi C; Brendolan A; Bordoni V; Carta MR; D'Intini V; Gastaldon F; Inguaggiato P; Ronco C
    Hemodial Int; 2003 Jun; 7(3):216-21. PubMed ID: 19379368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recommendations of iron management in chronic kidney patients].
    Canaud B
    Nephrol Ther; 2006 Nov; 2 Suppl 5():S356-62. PubMed ID: 17373284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron requirements in erythropoietin therapy.
    Eschbach JW
    Best Pract Res Clin Haematol; 2005 Jun; 18(2):347-61. PubMed ID: 15737895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for iron supplementation: oral versus intravenous.
    Macdougall IC
    Kidney Int Suppl; 1999 Mar; 69():S61-6. PubMed ID: 10084288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upper limit of serum ferritin: misinterpretation of the 2006 KDOQI anemia guidelines.
    Fishbane S
    Semin Dial; 2008; 21(3):217-20. PubMed ID: 18248518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and Management of Iron Deficiency in CKD: A Summary of the NICE Guideline Recommendations and Their Rationale.
    Ratcliffe LE; Thomas W; Glen J; Padhi S; Pordes BA; Wonderling D; Connell R; Stephens S; Mikhail AI; Fogarty DG; Cooper JK; Dring B; Devonald MA; Brown C; Thomas ME
    Am J Kidney Dis; 2016 Apr; 67(4):548-58. PubMed ID: 26763385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron supplementation in nephrology and oncology: what do we have in common?
    Macdougall IC
    Oncologist; 2011; 16 Suppl 3():25-34. PubMed ID: 21930832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous iron versus erythropoiesis-stimulating agents: friends or foes in treating chronic kidney disease anemia?
    Kalantar-Zadeh K; Streja E; Miller JE; Nissenson AR
    Adv Chronic Kidney Dis; 2009 Mar; 16(2):143-51. PubMed ID: 19233073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitude of physicians towards iron supplementation in hemodialysis patients treated with erythropoietin.
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2003; 14(2):134-44. PubMed ID: 18209438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance intravenous iron therapy in hepmodialysis patients receiving recombinant human erythropoientin.
    Romeh SA; Huraib S; Murray N; Tanimu D; Flaiw A; Iqbal A; Al Ghamdi G; Quadri K
    Saudi J Kidney Dis Transpl; 1999; 10(1):21-5. PubMed ID: 18212409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous iron: from anathema to standard of care.
    Auerbach M; Coyne D; Ballard H
    Am J Hematol; 2008 Jul; 83(7):580-8. PubMed ID: 18273906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing maintenance doses of lV iron in anemia management to improve patient outcomes.
    Nguyen TV; Wells D
    Nephrol Nurs J; 2011; 38(1):55-8; quiz 59. PubMed ID: 21469554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Iron metabolism pre and post the erythropoietin era].
    Jacobs C
    Nephrol Ther; 2006 Nov; 2 Suppl 5():S313-20. PubMed ID: 17373276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum prohepcidin and hepcidin in hemodialyzed patients undergoing iron therapy.
    Malyszko J; Malyszko JS; Mysliwiec M
    Kidney Blood Press Res; 2009; 32(4):235-8. PubMed ID: 19713706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of iron overload in thalassemia.
    Cianciulli P
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():208-13. PubMed ID: 19337180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietic agents, iron and hemoglobin--What happens beyond the trial setting: observational data from the ANZDATA registry.
    McDonald SP; Marshall MR; Kerr PG; Russ GR
    Hemodial Int; 2004 Jul; 8(3):257-64. PubMed ID: 19379425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Safety of parenteral iron therapy].
    Kessler M
    Nephrol Ther; 2006 Nov; 2 Suppl 5():S350-5. PubMed ID: 17373283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding iron overload: screening, monitoring, and caring for patients with transfusion-dependent anemias.
    Ault P; Jones K
    Clin J Oncol Nurs; 2009 Oct; 13(5):511-7. PubMed ID: 19793708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron and clinical outcomes in dialysis and non-dialysis-dependent chronic kidney disease patients.
    Kovesdy CP
    Adv Chronic Kidney Dis; 2009 Mar; 16(2):109-16. PubMed ID: 19233070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron storage indices and risk of bacterial infections in hemodialysis patients.
    Teehan GS; Ruthazer R; Balakrishnan VS; Snydman D; Jaber BL
    Hemodial Int; 2004 Jul; 8(3):226-32. PubMed ID: 19379422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.